R1	Has_index Arg1:T3 Arg2:T4	
R2	Has_temporal Arg1:T2 Arg2:T3	
R3	multi Arg1:T5 Arg2:T6	
R4	AND Arg1:T5 Arg2:T7	
R5	Has_index Arg1:T8 Arg2:T9	
R6	Subsumes Arg1:T7 Arg2:T8	
R7	Has_negation Arg1:T11 Arg2:T10	
R8	Has_index Arg1:T13 Arg2:T14	
R9	Has_context Arg1:T15 Arg2:T16	
R10	Has_qualifier Arg1:T18 Arg2:T19	
*	NOT T17 T18
*	OR T20 T21 T23
R11	Subsumes Arg1:T21 Arg2:T22	
R12	Subsumes Arg1:T18 Arg2:T20	
R13	Has_index Arg1:T31 Arg2:T32	
R14	Has_qualifier Arg1:T25 Arg2:T26	
*	OR T27 T29
R15	Has_multiplier Arg1:T25 Arg2:T27	
R16	Has_temporal Arg1:T25 Arg2:T31	
R17	Subsumes Arg1:T35 Arg2:T36	
R18	AND Arg1:T34 Arg2:T35	
R19	Has_multiplier Arg1:T37 Arg2:T39	
R20	Has_temporal Arg1:T37 Arg2:T38	
R21	Has_index Arg1:T38 Arg2:T40	
R22	Has_qualifier Arg1:T42 Arg2:T43	
R23	Subsumes Arg1:T43 Arg2:T44	
R24	Subsumes Arg1:T43 Arg2:T45	
R25	Has_index Arg1:T46 Arg2:T47	
R26	Has_temporal Arg1:T42 Arg2:T46	
R27	Has_temporal Arg1:T25 Arg2:T28	
R28	Has_temporal Arg1:T25 Arg2:T30	
T1	Non-query-able 0 36	Previous randomization in this study
T2	Drug 53 67	IV antibiotics
T3	Temporal 68 99	in the 6 weeks prior to Visit 1
T4	Reference_point 92 99	Visit 1
T5	Observation 101 137	Admission to the intensive care unit
T6	Visit 118 137	intensive care unit
T7	Condition 150 172	pulmonary exacerbation
T8	Temporal 173 206	in the two weeks prior to Visit 2
T9	Reference_point 199 206	Visit 2
T11	Procedure 238 262	desensitization protocol
T10	Negation 208 214	unless
T12	Condition 264 276	Pneumothorax
T13	Temporal 277 310	in the two weeks prior to Visit 2
T14	Reference_point 303 310	Visit 2
T15	Condition 312 329	Primary diagnosis
T16	Observation 334 357	current hospitalization
T17	Negation 361 370	unrelated
T18	Condition 384 410	lower respiratory symptoms
T19	Qualifier 374 383	worsening
T20	Condition 418 437	pulmonary clean out
T21	Condition 439 477	distal intestinal obstruction syndrome
T22	Condition 479 483	DIOS
T23	Condition 486 495	sinusitis
T25	Condition 506 516	hemoptysis
T26	Qualifier 498 505	Massive
T27	Multiplier 528 536	> 250 cc
T28	Temporal 537 556	in a 24 hour period
T29	Multiplier 560 570	100 cc/day
T30	Temporal 571 594	over 4 consecutive days
T31	Temporal 605 638	in the two weeks prior to Visit 2
T32	Reference_point 631 638	Visit 2
T34	Condition 648 670	pulmonary exacerbation
T35	Condition 692 731	allergic bronchopulmonary aspergillosis
T36	Condition 733 737	ABPA
T38	Temporal 740 750;799 816	At Visit 1 more than 2 weeks
T37	Drug 822 832	prednisone
T39	Multiplier 847 856	>10mg/day
T40	Reference_point 743 750	Visit 1
T41	Condition 869 896	solid organ transplantation
T42	Drug 908 929	antimicrobial therapy
T43	Qualifier 939 968	non-tuberculous mycobacterium
T44	Qualifier 976 988	M. abscessus
T45	Qualifier 990 1006	M. avium complex
T46	Temporal 1008 1041	in the two weeks prior to Visit 2
T47	Reference_point 1034 1041	Visit 2
